Aetion

company

About

Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.

Details

Last Funding Type
Series B
Last Funding Money Raised
$27M
Industries
Analytics,Health Care,Software
Founded date
Jan 1, 2013
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Aetion, Inc.

Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers.

With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care.

Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$203.60M
Aetion has raised a total of $203.60M in funding over 2 rounds. Their latest funding was raised on May 11, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 11, 2021 Series C $110M 5 Warburg Pincus Detail
Aug 26, 2020 Series B $19M 3 EDBI Detail
Feb 5, 2019 Series B $27M 9 Detail
Apr 11, 2018 Series B $36.40M 5 New Enterprise Associates Detail
Mar 20, 2017 Series A $11.20M 3 Flare Capital Partners
Lakestar
Detail

Investors

Number of Lead Investors
Number of Investors
5
18
Aetion is funded by 18 investors. Warburg Pincus and EDBI are the most recent investors.
Investor Name Lead Investor Funding Round
Warburg Pincus Yes Series C
EDBI Yes Series B
B Capital Group Series C
Flare Capital Partners Series C
Foresite Capital Series C
New Enterprise Associates Series C
Greenspring Associates Series B
Johnson & Johnson Innovation – JJDC Series B
Sanofi Series B
UCB Series B

Employee Profiles

Number of Employee Profiles
24
Aetion has 24 current employee profiles, including Advisor Dan Gebremedhin
Advisor
Executive
Executive
Executive

Acquisition

Aetion has acquired 1 organizations. Their most recent acquisition was Replica Analytics on Jan 4, 2022. They acquired Replica Analytics for 0.

Date Company Name
Industry Acquisition Type Price
Analytics acquisition Detail